Skip to main content

Glucarpidase Pregnancy and Breastfeeding Warnings

Brand names: Voraxaze

Medically reviewed by Drugs.com. Last updated on Sep 28, 2023.

Glucarpidase Pregnancy Warnings

Animal studies have not been conducted. There are no controlled data in human pregnancy. The background birth defect and miscarriage risk for the indicated population is not known. In the US general population, the estimated major birth defect risk is 2 to 4% and the miscarriage risk is 15 to 20%.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

The manufacturer makes no recommendation regarding use during pregnancy.

US FDA pregnancy category: Not assigned

Comments:
-There is no data on use in pregnant women or animal studies to know this drugs risks, including the risk of fetal harm, major birth defects, miscarriage, or adverse maternal or fetal effects.
-This drug is administered in combination with methotrexate which may cause embryo-fetal harm; the methotrexate manufacturer product information should be consulted.

See references

Glucarpidase Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-There is no information regarding this drug on the presence in human milk, the effects on a breastfed infant, or effects on milk production.
-This drug is administered in combination with methotrexate; the methotrexate manufacturer product information should be consulted.

See references

See also

References for pregnancy information

  1. Product Information. Voraxaze (glucarpidase). BTG International Inc. 2012.

References for breastfeeding information

  1. Product Information. Voraxaze (glucarpidase). BTG International Inc. 2012.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer